Analysts Predict 10% Growth for DIVB Holdings in the Coming Months

Updated On: May 22, 2025 7:55 am

Analysts See Upside Potential for iShares Core Dividend ETF

In evaluating the ETFs within our coverage at ETF Channel, we compared each holding’s trading price to its average 12-month forward target price. For the iShares Core Dividend ETF (Symbol: DIVB), the implied analyst target price based on these holdings is $53.27 per unit.

Currently, DIVB is trading around $48.22 per unit, indicating a potential upside of 10.47% according to analysts’ forecasts. Key underlying holdings with significant upside include DENTSPLY SIRONA Inc (Symbol: XRAY), Victory Capital Holdings Inc (Symbol: VCTR), and Cohen & Steers Inc (Symbol: CNS). Specifically, XRAY is trading at $15.83 per share, which is 17.09% below its average target of $18.54. Similarly, VCTR, priced at $61.68, has a target of $72.00, suggesting an upside of 16.73%. Analysts believe that CNS, currently at $77.74, could reach a target price of $90.00, reflecting a potential increase of 15.77%. The chart below illustrates the price performance of XRAY, VCTR, and CNS over the past twelve months:

XRAY, VCTR, and CNS Relative Performance Chart

Here’s a summary table of current analyst target prices for these stocks:

Name	Symbol	Recent Price	Avg. Analyst 12-Mo. Target	% Upside to Target
iShares Core Dividend ETF	DIVB	$48.22	$53.27	10.47%
DENTSPLY SIRONA Inc	XRAY	$15.83	$18.54	17.09%
Victory Capital Holdings Inc	VCTR	$61.68	$72.00	16.73%
Cohen & Steers Inc	CNS	$77.74	$90.00	15.77%

Investors may wonder whether analysts’ targets are justified or overly optimistic. A high target price compared to a stock’s trading price may signal strong future potential, yet it could also indicate outdated projections that might lead to target price downgrades. These considerations warrant thorough investor research.

10 ETFs With Most Upside To Analyst Targets »